One-pot, four-component synthesis of benzylpyrazolyl naphthoquinone derivatives and molecular docking studies

References

• Prasanna, P.; Perumal, S.; Menéndez, J. C. Chemodivergent, multicomponent domino reactions in aqueous media: L-proline-catalyzed assembly of densely functionalized 4H-pyrano[2,3-c]-pyrazoles and bispyrazolyl propanoates from simple, acyclic starting materials. Green Chem. 2013, 15, 1292–1299.
   Web of Science ®Google Scholar
• Nefzi, A.; Ostresh, J. M.; Houghten, R. A. The current status of heterocyclic combinatorial libraries. Chem. Rev. 1997, 97, 449–472.
   PubMed Web of Science ®Google Scholar
• Li, C. Organic reactions in aqueous media with a focus on carbon–carbon bond formations: A decade update. Chem. Rev. 2005, 105, 3095–3166.
   PubMed Web of Science ®Google Scholar
• Kobayashi, S.; Hamada, T.; Manabe, K. The catalytic asymmetric Mannich-type reactions in aqueous media. J. Am. Chem. Soc. 2002, 124, 5640–5641.
   PubMed Web of Science ®Google Scholar
• Han, Y.-F.; Xia, M. Multicomponent synthesis of cyclic frameworks on Knoevenagel-initiated domino reactions. Curr. Org. Chem. 2010, 14, 379–413.
   Web of Science ®Google Scholar
• Bigi, F.; Quarantelli, C. The Knoevenagel condensation in water. C. Curr. Org. Synth. 2012, 9, 31–39.
   Web of Science ®Google Scholar
• Berghot, M. A.; Kandeel, E. M.; Abdel-Rahman, A. H.; Abdel-Motaal, M. Synthesis, antioxidant, and cytotoxic activities of novel naphthoquinone derivatives from 2,3-dihydro-2,3-epoxy-1,4-naphthoquinone: A synthesis of trisquinones. J. Org. Chem. 1998, 63, 5726–5727.
   PubMed Web of Science ®Google Scholar
• Lee, E. J.; Lee, H. J.; Park, H. J.; Min, H. Y.; Suh, M. E.; Chung, H. J.; Lee, S. K. Induction of G2/M cell cycle arrest and apoptosis by a benz[f]indole-4,9-dione analog in cultured human lung (A549) cancer cells. Bioorg. Med. Chem. Lett. 2004, 14, 5175–5178.
   PubMed Web of Science ®Google Scholar
• Kim, B.; Yoo, J.; Park, S. H.; Jung, J. K.; Cho, H.; Chung, Y. Synthesis and evaluation of antitumor activity of novel 1,4-naphthoquinone derivatives (IV). Arch. Pharm. Res. 2000, 29, 123–130.
   Web of Science ®Google Scholar
• Tran, T.; Saheba, E.; Arcerio, A. V.; Chavez, V.; Q, Li. Y.; Martinez, L. E.; Primm, T. P. Quinones as antimycobacterial agents. Bioorg. Med. Chem. 2004, 12, 4809–4813.
   PubMed Web of Science ®Google Scholar
• Silva Jr., E. N.; Deus, C. F.; Cavalcanti, B. C.; Pessa, C.; Costa-Lotufo, L. V.; Montenegro, R. C.; Moraes, M. O.; Pinto, M. C. F. R.; Simone, C. A.; Ferreira, V. F.; Goulart, M. O. F.; Andrade, C. K. Z.; Pinto, A. V. 3-Arylamino and 3-alkoxy-nor-β-lapachone derivatives: Synthesis and cytotoxicity against cancer cell lines. J. Med. Chem. 2010, 53, 504–508.
   PubMed Web of Science ®Google Scholar
• Lien, J. C.; Huang, L. J.; Wang, J. P.; Teng, C. M.; Lee, K. H.; Kuo, S. C. Synthesis and antiplatelet, anti-inflammatory and antiallergic activities of 2-substituted 3-chloro-1,4-naphthoquinone derivatives. Bioorg. Med. Chem. 1997, 5, 2111–2120.
   PubMed Web of Science ®Google Scholar
• Consolacao, M. D.; Linardi, F.; Oliveira, M. M. D.; Sampaio, M. R. P. Lapachol derivative active against mouse lymphocytic leukemia P-388. J. Med. Chem. 1975, 18, 1159–1161.
   PubMed Web of Science ®Google Scholar
• Subramanian, S.; Ferreira, M. M. C.; Trsic, M. A structure–activity relationship study of lapachol and some derivatives of 1,4-naphthoquinones against carcinosarcoma Walker 256. Struct. Chem. 1998, 9, 47–57.
   Web of Science ®Google Scholar
• Raval, J. P.; Desai, K. G.; Desai, K. R. Microwave synthesis, characterization, and antimicrobial study of new pyrazolyl-oxopropyl-quinazolin-4(3H)-one derivatives. J. Saudi Chem. Soc. 2012, 16, 387–393.
   Web of Science ®Google Scholar
• Bondock, S.; Rabie, R.; Etman, H. A.; Fadda, A. A. Synthesis and antimicrobial activity of some new heterocycles incorporating antipyrine moiety. Eur. J. Med. Chem. 2008, 43, 2122–2129.
   PubMed Web of Science ®Google Scholar
• Himly, M.; Jahn-Schmid, B.; Pittertschatscher, K.; Bohle, B.; Grubmayr, K.; Ferreira, F.; Ebner, H.; Ebner, C. IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. J. Allergy Clin. Immunol. 2003, 111, 882–888.
   PubMed Web of Science ®Google Scholar
• Watanabe, T.; Yuki, S.; Egawa, M.; Nishi, H. Protective effects of MCI-186 on cerebral ischemia: Possible involvement of free radical scavenging and antioxidant actions. J. Pharmacol. Exp. Ther. 1994, 268, 1597–1604.
   PubMed Web of Science ®Google Scholar
• Wu, T. W.; Zeng, L. H.; Wu, J. K. P. Myocardial protection of MCI-186 in rabbit ischemia–reperfusion. Fung. Life Sci. 2002, 71, 2249–2255.
   PubMed Web of Science ®Google Scholar
• Rani, M.; Mohamad, Y. Synthesis, studies and in vitro antibacterial activity of some 5-(thiophene-2-yl)-phenyl pyrazoline derivatives. J. Saudi Chem. Soc. 2014, 18, 411–417.
   Web of Science ®Google Scholar
• Castagnolo, D.; Manetti, F.; Radi, M.; Bechi, B.; Pagano, M.; De Logu, A.; Meleddu, R.; Saddi, M.; Botta, M. Biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis, part 2: Synthesis of rigid. Bioorg. Med. Chem. 2009, 17, 5716–5721.
   PubMed Web of Science ®Google Scholar
• Badawey, E. A. M.; EI-Ashmawey, I. M. Nonsteroidal anti-inflammatory agents, part 1: Antiinflammatory, analgesic, and antipyretic activity of some new 1-(pyrimidin-2-yl)-3-pyrazolin-5-ones and 2-(pyrimidin-2-yl)-1,2,4,5,6,7-hexahydro-3H-indazol-3-ones. Eur. J. Med. Chem. 1998, 33, 349–362.
   Web of Science ®Google Scholar
• Selvam, T. P.; Kumar, P. V.; Saravanan, G.; Prakash, C. R. Microwave-assisted synthesis, characterization, and biological activity of novel pyrazole derivatives. J. Saudi Chem. Soc. 2014, 18, 1015–1021.
   Web of Science ®Google Scholar
• Sankappa Rai, U.; Isloor, A. M.; Shetty, P.; Pai, K. S. R.; Fun, H. K. Synthesis and in vitro biological evaluation of new pyrazole chalcones and heterocyclic diamides as potential anticancer agents. Arab. J. Chem. 2015, 8, 317–321.
   Web of Science ®Google Scholar
• Morris, S. W.; Naeve, C.; Mathew, P.; James, P. L.; Kirstein, M. N.; Cui, X.; Witte, D. P. ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin’s lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene 1997, 14, 2175–2188.
   PubMed Web of Science ®Google Scholar
• Pulford, K.; Lamant, L.; Morris, S. W.; Butler, L. H.; Wood, K. M.; Stroud, D.; Delsol, G.; Mason, D. Y. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood. 1997, 89, 1394–1404.
   PubMed Web of Science ®Google Scholar
• Mosse, Y. P.; Wood, A.; Maris, J. M. Inhibition of ALK signaling for cancer therapy. Clin. Cancer Res. 2015, 22, 948–960.
   PubMed Web of Science ®Google Scholar
• Shaw, A. T.; Solomon, B. Targeting anaplastic lymphoma kinase in lung cancer. Clin. Cancer Res. 2011, 17, 2081–2086.
   PubMed Web of Science ®Google Scholar
• Wang, S.; Ding, J.; Shi, F.; Liu, Y.; Jiang, B.; Ma, N.; Tu, S. Green synthesis of 3-hydroxynaphthalene-1,4-dione derivatives via microwave-assisted three-component reactions in neat water. J. Heterocycl. Chem. 2012, 49, 521–525.
   Web of Science ®Google Scholar
• Ramon, D. J.; Yus, M. Asymmetric multicomponent reactions (AMCRs): The new frontier. Angew. Chem. Int. Ed. 2005, 44, 1602–1634.
   PubMed Web of Science ®Google Scholar